C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2001
10/11/2001	WO2001074849A2 Binding peptides for carcinoembryonic antigen (cea)
10/11/2001	WO2001074848A2 Immunodominant acetylcholine receptor alpha subunit peptides, complexes thereof with mhc class ii components and their use
10/11/2001	WO2001074847A2 T-cell epitope of mage-12 and related nucleic acids, vectors, cells, compositions and methods of inducing an immune response to cancer
10/11/2001	WO2001074845A2 Immunogenic peptides derived from prostate-specific membrane antigen (psma) and uses thereof
10/11/2001	WO2001074844A2 Selective linear peptides with melanocortin-4 receptor (mc4-r) agonist activity
10/11/2001	WO2001074843A1 Process for preparing coagulants for water treatment
10/11/2001	WO2001074841A1 Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis
10/11/2001	WO2001074838A1 Dna molecules encoding l-glutamate-gated chloride channels from rhipicephalus sanguineus
10/11/2001	WO2001074836A1 Novel bone marrow nucleic acids and polypeptides
10/11/2001	WO2001074403A1 Combination of p53 gene and e1b-deleted p53 gene
10/11/2001	WO2001074383A1 Chimeric antigen-enterotoxin mucosal immunogens
10/11/2001	WO2001074379A2 Methods for inducing angiogenesis using morphogenic proteins and stimulatory factors
10/11/2001	WO2001074377A1 Non-mammalian gnrh analogs and uses thereof in tumor cell growth regulation and cancer therapy
10/11/2001	WO2001074375A1 Composition for treatment of autoimmune disease
10/11/2001	WO2001074349A1 Butylnitrone containing compositons for inhibition of cancer development
10/11/2001	WO2001074299A2 Compositions and methods for inhibition of cancer invasion and angiogenesis
10/11/2001	WO2001074297A2 Methods and compositions utilizing an alternative splice variant of the sigma-1 receptor
10/11/2001	WO2001074295A2 Phospholipid scramblases and methods of use thereof
10/11/2001	WO2001074163A1 Compositions and methods of using hiv vpr
10/11/2001	WO2001074144A1 Plant gene required for male meiosis
10/11/2001	WO2001074130A2 A computer based method for identifying conserved invariant peptide motifs
10/11/2001	WO2001074128A2 A novel polypeptide, microtubulin 11 and the polynucleotide encoding the polypeptide
10/11/2001	WO2001066585A8 A new polypeptide-human protease regulatory protein 10 and the p olynucleotide encoding it
10/11/2001	WO2001056627A8 Medical device coated with antimicrobial peptides
10/11/2001	WO2001049317A3 Enhancing the immune response to an antigen by presensitizing with an inducing agent prior to immunizing with the inducing agent and the antigen
10/11/2001	WO2001045746A3 Methods and compositions for prolonging elimination half-times of bioactive compounds
10/11/2001	WO2001044281A3 Human secretin-like g-protein coupled receptor
10/11/2001	WO2001042781A9 Supracolonic aerodigestive neoplasm detection
10/11/2001	WO2001040268A3 Beryllofluoride analogues of acyl phosphate polypeptides
10/11/2001	WO2001036640A3 Human fgf-21 gene and gene expression products
10/11/2001	WO2001032873A8 Insulin-responsive sequence dna binding protein-1' (irsdbp-1), gene encoding it and uses thereof
10/11/2001	WO2001032702A9 Molecular structure of rhd negative locus
10/11/2001	WO2001031003B1 Cloning, expression and characterisation of a gene expressed in tumour cells and involved in the regulation of the immune response
10/11/2001	WO2001027612A3 Immuno-chromatographic rapid assay in order to detect acid-resistant microorganisms in the stool
10/11/2001	WO2001025269A3 Human g-protein coupled receptor
10/11/2001	WO2001023521A9 Polypeptide derivatives of parathyroid hormone (pth)
10/11/2001	WO2001021807A8 Hepatitis c virus envelope two protein (e2) which lacks all or part of the hypervariable region one (hvr1), corresponding nucleic acids, chimeric viruses and uses thereof
10/11/2001	WO2001021799B1 Traf4 associated cell cycle proteins, compositions and methods of use
10/11/2001	WO2001021655A3 Virulence gene and protein, and their use
10/11/2001	WO2001020025A3 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications
10/11/2001	WO2001020021A3 Complex with specific dephosphorylating enzymes, effectors and method for the production of said complex.
10/11/2001	WO2001018038A3 Isoforms of snare molecules and the uses thereof in modulation of cellular exocytosis
10/11/2001	WO2001009301A3 Nucleic acids and polypeptides of invertebrate twik channels and methods of use
10/11/2001	WO2001007625A3 Ehrlichia canis genes and vaccines
10/11/2001	WO2001007621A3 Dna sequences coding for abc transporters
10/11/2001	WO2001007470A3 Human nervous system-associated proteins
10/11/2001	WO2001004143A3 Prostase vaccine
10/11/2001	WO2001001627A3 Server-assisted regeneration of a strong secret from a weak secret
10/11/2001	WO2000066773A3 Method of detection of cytochrome b mutations in funghi leading to resistance against anti-fungal agents
10/11/2001	WO2000065077A8 Triple hybrid amplicon vector systems to generate retroviral packaging lines
10/11/2001	WO2000063382A9 Genes and expression products from hematopoietic cells
10/11/2001	WO2000053730A9 Medical preparations for the treatment of alpha-galactosidase a deficiency
10/11/2001	WO2000050633A9 Method for cloning signal transduction intermediates
10/11/2001	WO2000026248A3 Tuberculosis diagnostic test
10/11/2001	WO2000026240A3 Streptococcal alpha2m-binding protein
10/11/2001	US20010029617 Therapeutic and diagnostic tools for impaired glucose tolerance conditions
10/11/2001	US20010029295 Isolated polynucleotide
10/11/2001	US20010029293 Icam-related protein
10/11/2001	US20010029251 Administering cytomegalo virus protein
10/11/2001	US20010029046 A deepithelialized skin diffusion cell system comprising, donor and receptor compartments, and a deepithelized skin sample when placed its deepithelialized side faces into donar compartment and dermal side faces into receptor compartment
10/11/2001	US20010029043 Prokaryotic; transformed with nucleic acid encoding papillomavirus virus major capsid protein that assembles within, such as Salmonella, to form chimeric virus like particles; anticancer, antitumor vaccine
10/11/2001	US20010029040 Agent for gene therapy of dilated cardomyopathy
10/11/2001	US20010029034 Hemostasis system-related disorders treatment
10/11/2001	US20010029033 Novel gene rno upregulated in leukemia cells by nitric oxide and DMSO
10/11/2001	US20010029032 Diagnosis and identifying agonists, antagonists useful in therapy
10/11/2001	US20010029031 Polynucleotides encoding human sodium bicarbonate cotransporters
10/11/2001	US20010029030 Novel trail receptors, nucleic acids encoding same, and methods of use thereof
10/11/2001	US20010029015 For detecting mutations and polymorphisms in torsin genemedical diagnosis
10/11/2001	US20010029013 Useful in modulating apoptosis; diagnosis of prostate/ovarian cancer, and leukemia
10/11/2001	US20010028885 Bovine footrot treatment and prevention
10/11/2001	US20010028883 Papillomavirus cellular receptor
10/11/2001	US20010028882 Anti-cryptosporidium parvum preparations
10/11/2001	EP1144447A3 Tuberculosis diagnostic test
10/11/2001	DE19953478A1 Genetically modified yeast lacking endogenous potassium transport activity, useful for identifying e.g. antiarrhythmic agents, includes a functional human potassium channel
10/11/2001	DE10017057A1 New ribosomal L1 protein gene from coryneform bacteria, useful, when downregulated, for increasing fermentative production of amino acids
10/11/2001	DE10013619A1 New polypeptide subunit of invertebrate ligand-controlled anion channel, useful in screening for potential plant-protection agents, especially insecticides
10/11/2001	DE10013204A1 DNA-Sequenz und Verfahren zur in vivo-Markierung und Analyse von DNA/Chromatin in Zellen DNA sequence and methods for in vivo labeling and analysis of DNA / chromatin in cells
10/11/2001	DE10012604A1 Transgenic animal expressing indicator gene specifically in the nervous system, useful for developing and testing therapeutic and diagnostic methods and agents
10/11/2001	CA2413211A1 A gene differentially expressed in breast and bladder cancer and encoded polypeptides
10/11/2001	CA2408904A1 Compositions and methods of using hiv vpr
10/11/2001	CA2405484A1 Immunodominant acetylcholine receptor alpha subunit peptides, complexes thereof with mhc class ii components and their use
10/11/2001	CA2405473A1 Dna molecules encoding ligand gated ion channels from dermacentor variabilis
10/11/2001	CA2405448A1 Method of examining cancer by assaying autoantibody against mdm2 and reagent therefor
10/11/2001	CA2405332A1 Fluorescence assay for gamma-secretase activity and inhibitors
10/11/2001	CA2405319A1 Methods and compositions for modulating integrin-mediated cell-cell interactions
10/11/2001	CA2405035A1 Improved method for the production of bacterial toxins
10/11/2001	CA2404961A1 Method for producing authentic cytokines in plants
10/11/2001	CA2404896A1 Human ion channel protein and polynucleotides encoding the same
10/11/2001	CA2404572A1 Inhibition of thrombosis by treatment with p-selectin antagnosits
10/11/2001	CA2404567A1 Process for producing recombinant protein
10/11/2001	CA2404555A1 Novel nucleic acids and polypeptides
10/11/2001	CA2404541A1 G-protein coupled receptors and nucleic acids encoding same
10/11/2001	CA2404526A1 Protein amf-1 to amf-10 and nucleic acids encoding the same
10/11/2001	CA2404519A1 Wnt-7b-like polypeptides and nucleic acids encoding same
10/11/2001	CA2404501A1 Method and materials relating to insulin-like growth factor binding protein-like polypeptides and polynucleotides
10/11/2001	CA2404484A1 Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis
10/11/2001	CA2404479A1 Hybrid cytokine of il-7 and .beta.-chain of hepatocyte growth factor
10/11/2001	CA2404291A1 Butylnitrone containing compositons for inhibition of cancer development
10/11/2001	CA2404257A1 Novel protein, dna thereof and process for producing the same
10/11/2001	CA2404074A1 Human polynucleotides, polypeptides, and antibodies

1 ... 1952 1953 1954 1955 1956 1957 1958 1959 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 1970 1971 1972 ... 2916